The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF

Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas

VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines

Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids

Functional characterization of a new deletion in CDKN1B 5'-UTR region

Pathological markers of aggressive pituitary tumour behaviour

MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic?

Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients

EGFR and IGF1R Impair Sunitinib Activity and May Represent Novel Targets for Broncho-Pulmonary Neuroendocrine Neoplasm Treatment

Dose and Time-Dependent Effect of Chloroquine on Autophagosome Generation in a Typical Bronchial Carcinoid Cell Line

Evaluation of NEP-SCORE Applicability in a Series of Patients with IV Stage NEN

CDK-Inhibitors as New Therapeutic Treatment for Human Bronchial Carcinoids

Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids

mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids

ctivation of EGFR promotes ACC cell proliferation by inducing VEGF autocrine secretion

PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability

mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line

Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines

miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta

miR-26a and cell cycle control in ACTH secreting pituitary adenoma